Feasibility of conversion thoracoscopic esophagectomy after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma

被引:6
作者
Kubo, Kentaro [1 ]
Kanematsu, Kyohei [1 ]
Kurita, Daisuke [1 ]
Ishiyama, Koshiro [1 ]
Oguma, Junya [1 ]
Itami, Jun [2 ]
Daiko, Hiroyuki [1 ]
机构
[1] Natl Canc Ctr, Dept Esophageal Surg, Tokyo, Japan
[2] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan
关键词
esophageal cancer; conversion surgery; thoracoscopic esophagectomy; MINIMALLY INVASIVE ESOPHAGECTOMY; PRONE POSITION; DOSE CHEMORADIOTHERAPY; SALVAGE ESOPHAGECTOMY; PHASE-II; CANCER; CISPLATIN; DOCETAXEL; SURGERY; 5-FLUOROURACIL;
D O I
10.1093/jjco/hyab085
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Recently, patients with cT4b esophageal cancer often require conversion surgery following induction therapy, for which the standard procedure is open esophagectomy. However, thoracoscopic esophagectomy, including thoracoscopic esophagectomy in the prone position, is increasingly used. We compared short-term outcomes of thoracoscopic esophagectomy and open esophagectomy in this setting. Methods: We retrospectively analyzed 14 patients who underwent thoracoscopic esophagectomy, and 10 who underwent open esophagectomy, for locally advanced unresectable esophageal cancer after induction therapy between March 2007 and July 2020. Results: The two groups did not significantly differ in patient background. Median total and thoracic surgical times were both significantly longer for open esophagectomy than for thoracoscopic esophagectomy. Median blood loss was also greater in the open esophagectomy group than in the thoracoscopic esophagectomy group. The thoracoscopic esophagectomy group also had significantly shorter median chest drain duration; and lower C-reactive protein levels on the second and third postoperative days. The two groups did not significantly differ in total complications or postoperative hospital stay. Conclusions: Thoracoscopic esophagectomy is as safe and feasible as open esophagectomy for conversion surgery after induction therapy for locally advanced unresectable esophageal squamous cell carcinoma.
引用
收藏
页码:1225 / 1231
页数:7
相关论文
共 26 条
[1]   Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil [J].
Abe, Tetsuya ;
Higaki, Eiji ;
Hosoi, Takahiro ;
Nagao, Takuya ;
Bando, Hideaki ;
Kadowaki, Shigenori ;
Muro, Kei ;
Tanaka, Tsutomu ;
Tajika, Masahiro ;
Niwa, Yasumasa ;
Shimizu, Yasuhiro .
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (02) :712-721
[2]   Chemoradiotherapy and surgery for T4 esophageal cancer in Japan [J].
Akutsu, Yasunori ;
Matsubara, Hisahiro .
SURGERY TODAY, 2015, 45 (11) :1360-1365
[3]   Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial [J].
Biere, Surya S. A. Y. ;
Henegouwen, Mark I. van Berge ;
Maas, Kirsten W. ;
Bonavina, Luigi ;
Rosman, Camiel ;
Roig Garcia, Josep ;
Gisbertz, Suzanne S. ;
Klinkenbijl, Jean H. G. ;
Hollmann, Markus W. ;
de lange, Elly S. M. ;
Bonjer, H. Jaap ;
van der Peet, Donald L. ;
Cuesta, Miguel A. .
LANCET, 2012, 379 (9829) :1887-1892
[4]  
Bierley JD., 2017, TNM classification of malignant tumors, V8th
[5]   A pilot study of the technical and oncologic feasibility of thoracoscopic esophagectomy with extended lymph node dissection in the prone position for clinical stage I thoracic esophageal carcinoma [J].
Daiko, Hiroyuki ;
Nishimura, Mitsuyo .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2012, 26 (03) :673-680
[6]   An anatomical hypothesis: a "concentric-structured model" for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection [J].
Fujiwara, H. ;
Kanamori, J. ;
Nakajima, Y. ;
Kawano, T. ;
Miura, A. ;
Fujita, T. ;
Akita, K. ;
Daiko, H. .
DISEASES OF THE ESOPHAGUS, 2019, 32 (08)
[7]   Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma [J].
Hara, Hiroki ;
Tahara, Makoto ;
Daiko, Hiroyuki ;
Kato, Ken ;
Igaki, Hiroyasu ;
Kadowaki, Shigenori ;
Tanaka, Yoichi ;
Hamamoto, Yasuo ;
Matsushita, Hisayuki ;
Nagase, Michitaka ;
Hosoya, Yoshinori .
CANCER SCIENCE, 2013, 104 (11) :1455-1460
[8]   Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs [J].
Ikeda, K ;
Ishida, K ;
Sato, N ;
Koeda, K ;
Aoki, K ;
Kimura, Y ;
Iwaya, T ;
Ogasawara, S ;
Iijima, S ;
Nakamura, R ;
Uesugi, N ;
Maesawa, C ;
Saito, K .
DISEASES OF THE ESOPHAGUS, 2001, 14 (3-4) :197-201
[9]   Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan esophageal oncology group (JEOG)/Japan clinical oncology group trial (JCOG9516) [J].
Ishida, K ;
Ando, N ;
Yamamoto, S ;
Ide, H ;
Shinoda, M .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (10) :615-619
[10]   Does staged surgical training for minimally invasive esophagectomy have an impact on short-term outcomes? [J].
Ishiyama, Koshiro ;
Fujita, Takeo ;
Fujiwara, Hisashi ;
Kurita, Daisuke ;
Oguma, Junya ;
Katai, Hitoshi ;
Daiko, Hiroyuki .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2021, 35 (11) :6251-6258